» Articles » PMID: 36970957

Evaluation of Simple Markers of Inflammation and Systemic Immune Inflammation Index in Schizophrenia, Bipolar Disorder Patients and Healthy Controls

Overview
Specialty Psychiatry
Date 2023 Mar 27
PMID 36970957
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), monocyte-lymphocyte ratio (MLR), mean platelet volume (MPV), and systemic immune inflammation index (SII) are recently used as indicators of inflammation. NLR, PLR, MLR, and MPV have been evaluated in many studies in patients with schizophrenia and bipolar disorder. However, there are no studies investigating SII. This study aims to evaluate NLR, PLR, MLR, MPV and SII values and complete blood count elements in patients hospitalized with diagnoses of the schizophrenia with psychotic episode and bipolar disorder with manic episode by comparing them with the control group.

Method: A total of 149 patients who were hospitalized with the diagnoses of the schizophrenia with psychotic episode and bipolar disorder with manic episode and who met the inclusion criteria were included in our study where the control group was composed of 66 healthy individuals. White blood cell (WBC), neutrophil, lymphocyte, platelet, and monocyte counts were obtained retrospectively from complete blood counts at the time of admission, based on which NLR, PLR, MLR, and SII were calculated.

Results: In this study, higher NLR, PLR, and SII values and lower MPV and lymphocyte counts were observed in schizophrenia patients compared to the control group. NLR, PLR, and SII values and neutrophil counts were higher in patients with bipolar disorder compared to the control group. Lower MPV values were found in patients with schizophrenia compared to patients with bipolar disorder.

Conclusion: Simple inflammatory and SII values in our study indicate the presence of low-grade systemic inflammation in schizophrenia and bipolar disorder.

Citing Articles

Differences in Blood Leukocyte Subpopulations in Schizophrenia: A Systematic Review and Meta-Analysis.

Dudeck L, Nussbaumer M, Nickl-Jockschat T, Guest P, Dobrowolny H, Meyer-Lotz G JAMA Psychiatry. 2025; .

PMID: 40042836 PMC: 11883609. DOI: 10.1001/jamapsychiatry.2024.4941.


Neutrophil-to-lymphocyte, platelet-to-lymphocyte ratios and systemic immune-inflammation index in patients with post-traumatic stress disorder.

Yontar G, Mutlu E BMC Psychiatry. 2024; 24(1):966.

PMID: 39741243 PMC: 11686920. DOI: 10.1186/s12888-024-06439-y.


Evaluation of primary markers of inflammation and the systemic inflammation index in specific learning disabilities.

Avsar P, Kara T, Kocaman O, Akkus M Biomark Med. 2024; 18(20):907-916.

PMID: 39360657 PMC: 11509046. DOI: 10.1080/17520363.2024.2404387.


Evaluation of Complete Blood Cell Count Parameters and Their Role in Inflammation in Patients with Methamphetamine and Synthetic Cannabis Use Disorder.

Sehlikoglu S, Yildiz S, Kazgan Kilicaslan A, Kurt O, Gocum E, Almis B Psychiatry Clin Psychopharmacol. 2024; 34(2):134-143.

PMID: 39165890 PMC: 11332474. DOI: 10.5152/pcp.2024.23803.


Inflammation Markers in Patients with Bipolar Disorder Who Have Committed Offenses and Their Relationship with Criminal Behavior.

Emir B, Yildiz S, Kazgan Kilicaslan A, Kurt O, Ugur K, Tabara M Medicina (Kaunas). 2023; 59(10).

PMID: 37893443 PMC: 10608231. DOI: 10.3390/medicina59101725.


References
1.
Xiao T . Innate immunity and inflammation. Cell Mol Immunol. 2016; 14(1):1-3. PMC: 5214945. DOI: 10.1038/cmi.2016.45. View

2.
Dean B, Gibbons A, Tawadros N, Brooks L, Everall I, Scarr E . Different changes in cortical tumor necrosis factor-α-related pathways in schizophrenia and mood disorders. Mol Psychiatry. 2012; 18(7):767-73. DOI: 10.1038/mp.2012.95. View

3.
Ransing R, Patil S, Pevekar K, Mishra K, Patil B . Unrecognized Prevalence of Macrocytosis among the Patients with First Episode of Psychosis and Depression. Indian J Psychol Med. 2018; 40(1):68-73. PMC: 5795682. DOI: 10.4103/IJPSYM.IJPSYM_139_17. View

4.
Miller B, Buckley P, Seabolt W, Mellor A, Kirkpatrick B . Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry. 2011; 70(7):663-71. PMC: 4071300. DOI: 10.1016/j.biopsych.2011.04.013. View

5.
Yu Q, Weng W, Zhou H, Tang Y, Ding S, Huang K . Elevated Platelet Parameter in First-Episode Schizophrenia Patients: A Cross-Sectional Study. J Interferon Cytokine Res. 2020; 40(11):524-529. DOI: 10.1089/jir.2020.0117. View